Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Natco Pharma Limited
NATCOPHARMCurrent price
1 577.75 INR
-14.24 INR (-0.90%)
Last closed
1 582.5 INR
Company
www.natcopharma.co.in
ISIN
INE987B01026
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
National Stock Exchange of India
Capitalization
283 249 519 987 INR
Yield for 12 month
+15.36 %
1Y
3Y
5Y
10Y
15Y
NATCOPHARM
NATCO Pharma Limited, a pharmaceutical company, engages in the developing, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care. The company offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF. Further, the company offers agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India. Address: Natco House, Hyderabad, India, 500034
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
87 862.11 INRP/E ratio
17.3008Dividend Yield
0.79 %Current Year
+39 950 865 817 INR
Last Year
+27 045 861 004 INR
Current Quarter
+13 613 346 481 INR
Last Quarter
+10 673 079 389 INR
Current Year
+25 680 130 452 INR
Last Year
+20 778 686 278 INR
Current Quarter
+9 953 748 065 INR
Last Quarter
+7 270 242 343 INR
Key Figures NATCOPHARM
1 year
3 years
5 years
10 years
EBITDA
21 611 162 976 INR
Operating Margin TTM
PE Ratio
17.3008
Return On Assets TTM
16.84 %
PEG Ratio
–
Return On Equity TTM
25.88 %
Wall Street Target Price
87 862.11 INR
Revenue TTM
43 449 614 665 INR
Book Value
326.37 INR
Revenue Per Share TTM
Dividend Share
5.49 INR
Quarterly Revenue Growth YOY
19.5 %
Dividend Yield
0.79 %
Gross Profit TTM
20 521 924 958 INR
Earnings per share
91.39 INR
Diluted Eps TTM
91.39 INR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
60.4 %
Profit Margin
37.63 %
Dividend Analytics NATCOPHARM
Dividend growth over 5 years
12 %Continuous growth
2 yearsPayout Ratio 5 years average
32 %Dividend History NATCOPHARM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
12.5
Ex Dividend Date
23.08.2024
Forward Annual Dividend Yield
0.79 %
Last Split Factor
5:1
Payout Ratio
10.18 %
Last Split Date
26.11.2015
Dividend Date
–
Stock Valuation NATCOPHARM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
17.3008
Forward PE
17.6056
Enterprise Value Revenue
6.7757
Price Sales TTM
6.519
Enterprise Value EBITDA
14.399
Price Book MRQ
4.8426
Financials NATCOPHARM
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NATCOPHARM
For 52 weeks
720.12 INR
1 637.48 INR
50 Day MA
1 409.73 INR
Shares Short Prior Month
–
200 Day MA
1 078.32 INR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart